| Home > Publications Database > CSF levels of the somatodendritic protein MAP2 are increased in ALS and predict shorter survival. > Access to Fulltext |
| Restricted | |||||||
DZNE-2025-01265_Restricted
|
|||||||
| version 1 |
| ||||||